ATE366803T1 - Hohe zytokinproduktion mit verbesserte zelllebensfähigkeit - Google Patents

Hohe zytokinproduktion mit verbesserte zelllebensfähigkeit

Info

Publication number
ATE366803T1
ATE366803T1 AT00960038T AT00960038T ATE366803T1 AT E366803 T1 ATE366803 T1 AT E366803T1 AT 00960038 T AT00960038 T AT 00960038T AT 00960038 T AT00960038 T AT 00960038T AT E366803 T1 ATE366803 T1 AT E366803T1
Authority
AT
Austria
Prior art keywords
cell viability
cytokine production
improved cell
high cytokine
pkr
Prior art date
Application number
AT00960038T
Other languages
English (en)
Inventor
Allan Lau
Laura Browning
Michael Kiefer
Original Assignee
Genetrol Biotherapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetrol Biotherapeutics filed Critical Genetrol Biotherapeutics
Application granted granted Critical
Publication of ATE366803T1 publication Critical patent/ATE366803T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747Apoptosis related proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00960038T 1999-09-08 2000-09-08 Hohe zytokinproduktion mit verbesserte zelllebensfähigkeit ATE366803T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15285499P 1999-09-08 1999-09-08

Publications (1)

Publication Number Publication Date
ATE366803T1 true ATE366803T1 (de) 2007-08-15

Family

ID=22544735

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00960038T ATE366803T1 (de) 1999-09-08 2000-09-08 Hohe zytokinproduktion mit verbesserte zelllebensfähigkeit

Country Status (8)

Country Link
EP (1) EP1214399B1 (de)
JP (1) JP2003509025A (de)
AT (1) ATE366803T1 (de)
AU (1) AU7126000A (de)
CA (1) CA2383563A1 (de)
DE (1) DE60035515T2 (de)
HK (1) HK1048135A1 (de)
WO (1) WO2001018185A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031859A1 (en) * 1999-09-08 2001-10-18 Lau Allan S. High level cytokine production with enhanced cell viability
EP1220934B1 (de) * 1999-09-27 2005-12-21 Genentech, Inc. Verfahren zur herstellung von rekombinanten proteinen mittels inhibitoren von apoptose
JP2004529851A (ja) * 2000-09-12 2004-09-30 ジーントロール バイオセラピューティクス, インコーポレイテッド ヒトサイトカインの混合物を含む組成物およびその産生方法
WO2002022786A1 (en) 2000-09-14 2002-03-21 Genetrol Biotherapeutics, Inc. Method and cell composition for screening compounds for anti-inflammatory activity
US7678570B2 (en) 2004-03-01 2010-03-16 Kitakyushu Foundation For The Advancement Of Industry, Science And Technology Human cell strains for protein production, provided by selecting strains with high intracellular protein and mutating with carcinogens
US9005974B2 (en) 2005-12-09 2015-04-14 Academish Medisch Centrum Bij De Universiteit Van Amsterdam Means and methods for influencing the stability of cells
FI1974017T4 (fi) 2005-12-09 2023-09-14 Välineitä ja menetelmiä, joilla voidaan vaikuttaa vasta-ainetta tuottavien solujen stabiliteettiin
JP5781508B2 (ja) 2009-07-15 2015-09-24 アイム・セラピューティクス・べー・フェー 高親和性抗体を産生させるための手段および方法
EP2646466B1 (de) 2010-12-02 2017-03-29 AIMM Therapeutics B.V. Mittel und methoden zur produktion von hoch affinen antikörpern
WO2015115892A1 (en) 2014-01-31 2015-08-06 Aimm Therapeutics B.V. Means and methods for producing stable antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840565A (en) * 1995-08-22 1998-11-24 The Regents Of The University Of California Methods for enhancing the production of viral vaccines in PKR-deficient cell culture
US5976800A (en) * 1996-06-28 1999-11-02 The Regents Of The University Of California Enhancement of cancer cell death

Also Published As

Publication number Publication date
EP1214399B1 (de) 2007-07-11
EP1214399A1 (de) 2002-06-19
DE60035515T2 (de) 2008-04-17
AU7126000A (en) 2001-04-10
HK1048135A1 (zh) 2003-03-21
JP2003509025A (ja) 2003-03-11
WO2001018185A1 (en) 2001-03-15
CA2383563A1 (en) 2001-03-15
DE60035515D1 (de) 2007-08-23

Similar Documents

Publication Publication Date Title
DE69634360D1 (de) Methoden zur erhöhung der produktion von viralen impstoffen in zellkultur durch unterdrückung von interferon
DK1220934T3 (da) Fremgangsmåde til fremstilling af rekombinante proteiner med anvendelse af apoptoseinhibitorer
ATE359358T1 (de) Verfahren und medien zur kontrolle der sialysierung von proteinen, die von säugetierzellen produziert werden
ATE399855T1 (de) Tierzellkulturmedium mit pflanzlichen nährstoffen
ES2120946T3 (es) Sistemas y medios de cultivo celular.
ATE368103T1 (de) Isolierung, vermehrung und gezielte differenzierung von zäugetierstammzellen des zentralnervensystems
DE69740002D1 (de) Tierzellen und verfahren für die replikation von influenza viren
CA2264270A1 (en) Mass production of paclitaxel by changing the temperature of the medium during the plant cell culture
BR9805900B1 (pt) processo para integrar um fragmento de dna no genoma de uma célula de uma planta manocotiledÈnea.
WO2004081205A8 (en) Differentiation of human embryonic stem cells to cardiomyocytes
HK1093755A1 (en) Method for differentiating mesenchymal stem cell into neural cell
GB2429211A (en) Feeder independent extended culture of embryonic stem cells
WO2004090096A3 (en) Methods for neural differentiation of embryonic stem cells using protease passaging techniques
ATE366803T1 (de) Hohe zytokinproduktion mit verbesserte zelllebensfähigkeit
DE60138127D1 (de) Stoffwechseländerungen in gärungen zur produktion rekombinanter proteine
DK1495112T3 (da) Cellekulturmedium
WO2000077236A3 (en) Methods for enhancing the production of cytokines in cell cultur e
EP1334982A3 (de) Kristall des des löslichen Komplentrezeptors Typ 1
ATE258594T1 (de) Verfahren zur steigerung des wachstums von pflanzenzellkulturen
DE60310748D1 (de) Verfahren zur homogenen masskultivierung von t-lymphozyten
EP1676911A4 (de) Neue rekombinante tierzellen mit hoher proteinproduktion, verfahren zur konstruktion davon sowie verfahren zur massenproduktion von protein unter verwendung davon
WO2005054447A3 (en) Müller stem cells
ATE449162T1 (de) Herstellung von tcr gamma delta t-zellen
DE602004013986D1 (de) Verfahren zur hestellung eines extrakts für zellfreie proteinsynthese und damit hergestellter zellextrakt
CN106591295B (zh) 一种多功能干细胞培养方法及所用培养基

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties